EZETIMIBE

EZETIMIBE was reported 76886 times

EZETIMIBE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 61 0.8714
1 HYPER IGE SYNDROME 55 0.4825
2 TRUNCUS ARTERIOSUS PERSISTENT 71 0.3568
3 NEUROLOGIC NEGLECT SYNDROME 173 0.3112
4 TYPE IIA HYPERLIPIDAEMIA 65 0.2778
5 AMAUROSIS FUGAX 241 0.2238
6 LIPOPROTEIN (A) INCREASED 73 0.2232
7 CAROTID ARTERY THROMBOSIS 175 0.2061
8 LOW DENSITY LIPOPROTEIN ABNORMAL 80 0.1305
9 ADJUSTMENT DISORDER 169 0.1300
10 VASCULAR STENT STENOSIS 48 0.1140
11 CARDIAC SEPTAL DEFECT 59 0.0821
12 LOW DENSITY LIPOPROTEIN DECREASED 111 0.0783
13 LOW DENSITY LIPOPROTEIN INCREASED 584 0.0754
14 CONGENITAL CARDIOVASCULAR ANOMALY 63 0.0751
15 MUSCLE DISCOMFORT 55 0.0701
16 RESTRICTIVE PULMONARY DISEASE 82 0.0700
17 PERSONALITY DISORDER 179 0.0683
18 DIAPHRAGMATIC DISORDER 50 0.0654
19 NECROTISING MYOSITIS 53 0.0611
20 HIGH DENSITY LIPOPROTEIN DECREASED 180 0.0540
21 URINARY TRACT DISORDER 227 0.0504
22 MYOPATHY 432 0.0500
23 HYPERPARATHYROIDISM SECONDARY 120 0.0478
24 CAROTID ARTERIOSCLEROSIS 49 0.0475
25 PULMONARY PAIN 136 0.0465
26 MUSCLE CRAMP 79 0.0445
27 DYSLIPIDAEMIA 224 0.0441
28 HAEMORRHAGIC STROKE 338 0.0432
29 BLOOD CHOLESTEROL DECREASED 77 0.0413
30 BLOOD PRESSURE SYSTOLIC ABNORMAL 97 0.0392
31 POLYCYSTIC OVARIES 60 0.0387
32 ANGINA UNSTABLE 249 0.0383
33 NEPHROGENIC ANAEMIA 175 0.0377
34 IMMUNE-MEDIATED MYOSITIS 102 0.0370
35 BLOOD CREATINE PHOSPHOKINASE INCREASED 999 0.0347
36 ARTERIAL OCCLUSIVE DISEASE 269 0.0342
37 GANGRENE 198 0.0328
38 POLYMYOSITIS 55 0.0311
39 MYOGLOBIN BLOOD INCREASED 47 0.0307
40 BLOOD PRESSURE DIASTOLIC ABNORMAL 74 0.0291
41 INHIBITORY DRUG INTERACTION 46 0.0290
42 SENSORY LOSS 227 0.0282
43 RHABDOMYOLYSIS 1170 0.0280
44 OCULAR DISCOMFORT 307 0.0273
45 MYALGIA 4604 0.0271
46 ESSENTIAL HYPERTENSION 49 0.0267
47 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 107 0.0262
48 HYPERLIPIDAEMIA 307 0.0257
49 CORONARY ARTERY STENOSIS 129 0.0256
50 CAROTID ARTERY STENOSIS 89 0.0255
51 ANGINA PECTORIS 722 0.0252
52 AORTIC ARTERIOSCLEROSIS 63 0.0245
53 MUSCLE RUPTURE 95 0.0244
54 REBOUND ACID HYPERSECRETION 73 0.0241
55 HYPERURICAEMIA 99 0.0241
56 ARTERIOSCLEROSIS 226 0.0240
57 HEMIPLEGIA 197 0.0237
58 SINUS CONGESTION 317 0.0234
59 ISCHAEMIC CARDIOMYOPATHY 71 0.0231
60 LEFT VENTRICULAR HYPERTROPHY 99 0.0231
61 CORONARY ARTERY DISEASE 689 0.0227
62 BLOOD TRIGLYCERIDES INCREASED 402 0.0227
63 MYOSITIS 203 0.0226
64 HAEMATOCRIT INCREASED 51 0.0224
65 AMYOTROPHIC LATERAL SCLEROSIS 47 0.0218
66 GLUCOSE TOLERANCE IMPAIRED 127 0.0215
67 AORTIC STENOSIS 74 0.0212
68 MUSCLE FATIGUE 90 0.0212
69 CORONARY ARTERY OCCLUSION 291 0.0212
70 GENERALISED OEDEMA 260 0.0210
71 BLOOD CHOLESTEROL ABNORMAL 96 0.0208
72 MOTOR DYSFUNCTION 204 0.0200
73 ARTERIOSCLEROSIS CORONARY ARTERY 131 0.0198
74 AFFECT LABILITY 190 0.0197
75 HYPERCHOLESTEROLAEMIA 180 0.0186
76 BLOOD CHOLESTEROL INCREASED 857 0.0184
77 CAROTID ARTERY OCCLUSION 67 0.0183
78 POLYMYALGIA RHEUMATICA 57 0.0179
79 EUGLYCAEMIC DIABETIC KETOACIDOSIS 74 0.0179
80 MUSCLE DISORDER 145 0.0179
81 HEART DISEASE CONGENITAL 63 0.0178
82 DYSPNOEA AT REST 51 0.0176
83 DIABETIC NEUROPATHY 86 0.0174
84 SKIN HAEMORRHAGE 256 0.0173
85 TROPONIN INCREASED 131 0.0172
86 STENT PLACEMENT 138 0.0171
87 HEAD DISCOMFORT 301 0.0170
88 POTENTIATING DRUG INTERACTION 57 0.0170
89 ACUTE CORONARY SYNDROME 137 0.0165
90 SPINAL OSTEOARTHRITIS 143 0.0163
91 PRESYNCOPE 394 0.0162
92 SINUS DISORDER 318 0.0160
93 MUSCLE SPASTICITY 197 0.0160
94 INTERVERTEBRAL DISC DEGENERATION 147 0.0159
95 MITRAL VALVE INCOMPETENCE 178 0.0157
96 TRICUSPID VALVE INCOMPETENCE 124 0.0156
97 RESPIRATORY TRACT CONGESTION 246 0.0155
98 LIVER FUNCTION TEST ABNORMAL 450 0.0155
99 COORDINATION ABNORMAL 215 0.0154
100 PANCREATITIS ACUTE 345 0.0153
101 ALTERED STATE OF CONSCIOUSNESS 329 0.0152
102 MUSCLE ATROPHY 190 0.0150
103 END STAGE RENAL DISEASE 273 0.0150
104 HYPOVOLAEMIA 87 0.0149
105 CORONARY ARTERIAL STENT INSERTION 75 0.0148
106 CARDIAC FAILURE CHRONIC 63 0.0148
107 LEFT VENTRICULAR DYSFUNCTION 99 0.0148
108 HEMIPARESIS 249 0.0147
109 DIASTOLIC DYSFUNCTION 45 0.0146
110 SNEEZING 326 0.0145
111 PARANASAL SINUS DISCOMFORT 54 0.0143
112 ACUTE MYOCARDIAL INFARCTION 416 0.0141
113 AORTIC VALVE INCOMPETENCE 60 0.0141
114 HEPATIC STEATOSIS 262 0.0141
115 HAEMATEMESIS 356 0.0140
116 RHINITIS ALLERGIC 62 0.0139
117 MUSCULAR WEAKNESS 1582 0.0139
118 MYOCARDIAL ISCHAEMIA 157 0.0138
119 RENAL FAILURE CHRONIC 105 0.0136
120 DIVERTICULUM 97 0.0136
121 GOUT 244 0.0136
122 PHOTOPHOBIA 255 0.0135
123 DIPLOPIA 348 0.0134
124 BLOOD PRESSURE SYSTOLIC INCREASED 256 0.0131
125 SLEEP APNOEA SYNDROME 250 0.0131
126 OBESITY 208 0.0130
127 CORONARY ARTERY BYPASS 75 0.0130
128 PROTEIN URINE PRESENT 65 0.0130
129 DIVERTICULUM INTESTINAL 57 0.0130
130 TRIGGER FINGER 53 0.0130
131 RALES 75 0.0129
132 CHRONIC KIDNEY DISEASE 975 0.0128
133 HAEMATURIA 439 0.0128
134 CHRONIC SINUSITIS 48 0.0128
135 HAEMORRHAGIC ANAEMIA 56 0.0127
136 BLOOD PRESSURE DIASTOLIC DECREASED 94 0.0127
137 CARDIAC VALVE DISEASE 72 0.0126
138 VENTRICULAR SEPTAL DEFECT 72 0.0126
139 ELECTROCARDIOGRAM ABNORMAL 98 0.0125
140 HIATUS HERNIA 159 0.0123
141 HAEMOGLOBIN INCREASED 56 0.0123
142 HEPATIC CYTOLYSIS 156 0.0122
143 ACUTE KIDNEY INJURY 1872 0.0122
144 RENAL TUBULAR NECROSIS 119 0.0121
145 SPINAL STENOSIS 50 0.0121
146 AUTOIMMUNE HEPATITIS 84 0.0121
147 IRON DEFICIENCY 54 0.0120
148 CATHETERISATION CARDIAC 53 0.0119
149 STOMACH DISCOMFORT 61 0.0118
150 OBSTRUCTIVE AIRWAYS DISORDER 131 0.0118
151 EATING DISORDER 250 0.0117
152 RENAL CYST 93 0.0117
153 LARGE INTESTINE POLYP 81 0.0117
154 RESTLESS LEGS SYNDROME 212 0.0116
155 SPINAL COLUMN STENOSIS 55 0.0116
156 BUNDLE BRANCH BLOCK LEFT 49 0.0115
157 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 102 0.0115
158 VENTRICULAR EXTRASYSTOLES 119 0.0114
159 MUSCLE SPASMS 2096 0.0114
160 BODY HEIGHT DECREASED 121 0.0113
161 DYSPNOEA EXERTIONAL 425 0.0113
162 AORTIC ANEURYSM 85 0.0112
163 SKIN LACERATION 121 0.0111
164 NOCTURIA 135 0.0111
165 FLATULENCE 626 0.0110
166 GLOMERULAR FILTRATION RATE DECREASED 134 0.0109
167 VITAMIN D DEFICIENCY 106 0.0109
168 TRANSIENT ISCHAEMIC ATTACK 365 0.0108
169 CHROMATURIA 243 0.0108
170 SYNOVIAL CYST 49 0.0106
171 EXERCISE TOLERANCE DECREASED 61 0.0106
172 SEASONAL ALLERGY 149 0.0105
173 MYASTHENIA GRAVIS 85 0.0105
174 DUODENAL ULCER 74 0.0105
175 CYSTITIS 333 0.0104
176 BENIGN PROSTATIC HYPERPLASIA 54 0.0104
177 NASAL DRYNESS 65 0.0104
178 HYPERKALAEMIA 363 0.0103
179 ASCITES 304 0.0103
180 EYE PAIN 583 0.0103
181 LOWER GASTROINTESTINAL HAEMORRHAGE 76 0.0103
182 GASTROINTESTINAL MOTILITY DISORDER 55 0.0103
183 MELAENA 226 0.0103
184 HEPATIC ENZYME INCREASED 697 0.0102
185 BLOOD PRESSURE FLUCTUATION 245 0.0102
186 IRON DEFICIENCY ANAEMIA 94 0.0102
187 GASTROOESOPHAGEAL REFLUX DISEASE 816 0.0101
188 ASPARTATE AMINOTRANSFERASE INCREASED 538 0.0101
189 APHASIA 304 0.0101
190 INTERNATIONAL NORMALISED RATIO INCREASED 287 0.0101
191 MUSCULOSKELETAL DISCOMFORT 173 0.0100
192 DRUG INTERACTION 1593 0.0100
193 ATELECTASIS 97 0.0100
194 BRAIN FOG 156 0.0099
195 TUBULOINTERSTITIAL NEPHRITIS 186 0.0099
196 HYPOMAGNESAEMIA 138 0.0099
197 PERIPHERAL VASCULAR DISORDER 51 0.0099
198 ORTHOSTATIC HYPOTENSION 172 0.0099
199 ANURIA 85 0.0099
200 TINNITUS 452 0.0098
201 PEMPHIGOID 74 0.0098
202 IMPAIRED GASTRIC EMPTYING 133 0.0097
203 ALANINE AMINOTRANSFERASE INCREASED 599 0.0097
204 TYPE 2 DIABETES MELLITUS 327 0.0097
205 VITAMIN D DECREASED 83 0.0097
206 BLOOD URIC ACID INCREASED 56 0.0097
207 MYOCARDIAL INFARCTION 1686 0.0097
208 DIABETES MELLITUS INADEQUATE CONTROL 171 0.0096
209 BLOOD PRESSURE INCREASED 1476 0.0096
210 DRUG-INDUCED LIVER INJURY 302 0.0096
211 FAECES DISCOLOURED 208 0.0096
212 CARDIAC FLUTTER 62 0.0096
213 RHINORRHOEA 617 0.0095
214 DRUG INTOLERANCE 915 0.0095
215 FLUSHING 961 0.0094
216 ERECTILE DYSFUNCTION 242 0.0094
217 CATARACT 558 0.0094
218 UPPER-AIRWAY COUGH SYNDROME 77 0.0093
219 FOOD POISONING 50 0.0093
220 EXTRASYSTOLES 65 0.0093
221 LIPASE INCREASED 71 0.0093
222 ATRIOVENTRICULAR BLOCK COMPLETE 62 0.0093
223 DYSARTHRIA 348 0.0092
224 GASTRITIS 243 0.0092
225 GLYCOSYLATED HAEMOGLOBIN INCREASED 232 0.0092
226 MUSCULOSKELETAL CHEST PAIN 142 0.0092
227 ECONOMIC PROBLEM 139 0.0092
228 ATRIAL FIBRILLATION 892 0.0092
229 OSTEOARTHRITIS 387 0.0091
230 RENAL FAILURE ACUTE 387 0.0091
231 VENTRICULAR TACHYCARDIA 150 0.0091
232 ERUCTATION 175 0.0090
233 PURPURA 80 0.0090
234 BLOOD TEST ABNORMAL 127 0.0090
235 URINE ODOUR ABNORMAL 53 0.0090
236 POLYP 59 0.0090
237 PANCREATITIS 475 0.0090
238 DIZZINESS POSTURAL 87 0.0090
239 SHOCK HAEMORRHAGIC 73 0.0090
240 HEPATITIS CHOLESTATIC 54 0.0090
241 RENAL IMPAIRMENT 752 0.0089
242 BLOOD LACTIC ACID INCREASED 47 0.0089
243 HYPERTHYROIDISM 129 0.0089
244 ADRENAL INSUFFICIENCY 108 0.0089
245 OSTEOPENIA 135 0.0089
246 ODYNOPHAGIA 53 0.0089
247 CHOLANGITIS 55 0.0089
248 KNEE ARTHROPLASTY 186 0.0088
249 TYPE 1 DIABETES MELLITUS 53 0.0088
250 SWELLING OF EYELID 55 0.0088
251 MULTIPLE INJURIES 55 0.0087
252 CHOLESTASIS 167 0.0087
253 POOR QUALITY SLEEP 187 0.0087
254 CARDIAC MURMUR 75 0.0087
255 ATRIAL FLUTTER 69 0.0086
256 EOSINOPHIL COUNT INCREASED 72 0.0086
257 OESOPHAGITIS 94 0.0086
258 RENAL FAILURE 1141 0.0086
259 UROSEPSIS 79 0.0086
260 CARDIO-RESPIRATORY ARREST 358 0.0086
261 HYPERTRIGLYCERIDAEMIA 50 0.0085
262 UPPER GASTROINTESTINAL HAEMORRHAGE 143 0.0085
263 PAIN IN EXTREMITY 2503 0.0085
264 HYPERTRANSAMINASAEMIA 59 0.0085
265 BLOOD PRESSURE INADEQUATELY CONTROLLED 51 0.0085
266 DYSPEPSIA 834 0.0085
267 CHEST DISCOMFORT 868 0.0085
268 HAND FRACTURE 60 0.0085
269 HEART RATE DECREASED 296 0.0084
270 PYELONEPHRITIS 73 0.0084
271 RENAL INJURY 250 0.0084
272 ARTHRITIS 658 0.0084
273 OEDEMA PERIPHERAL 1019 0.0084
274 MUSCLE STRAIN 72 0.0083
275 HOT FLUSH 627 0.0083
276 GASTRIC ULCER HAEMORRHAGE 46 0.0083
277 CHOLECYSTITIS ACUTE 47 0.0083
278 TENDON DISORDER 54 0.0083
279 GASTROINTESTINAL PAIN 91 0.0083
280 BLINDNESS 337 0.0083
281 INFUSION SITE SWELLING 52 0.0083
282 HYPOGLYCAEMIA 400 0.0082
283 FLANK PAIN 77 0.0082
284 SYNCOPE 821 0.0082
285 HYPERKERATOSIS 45 0.0081
286 PROSTATIC SPECIFIC ANTIGEN INCREASED 112 0.0081
287 CATARACT OPERATION 48 0.0081
288 GROIN PAIN 71 0.0081
289 BLOOD UREA INCREASED 135 0.0081
290 EYE INFECTION 91 0.0081
291 JOINT DISLOCATION 85 0.0080
292 NEPHROPATHY 75 0.0080
293 ASTHENIA 3019 0.0080
294 TENDON RUPTURE 99 0.0080
295 PROTEINURIA 151 0.0079
296 LACTIC ACIDOSIS 257 0.0079
297 BACK PAIN 1843 0.0079
298 CHEST PAIN 1468 0.0079
299 CARDIAC FAILURE CONGESTIVE 633 0.0079
300 TENDERNESS 82 0.0079
301 DIVERTICULITIS 218 0.0079
302 ROTATOR CUFF SYNDROME 101 0.0079
303 BLOOD PRESSURE ABNORMAL 156 0.0078
304 ABNORMAL FAECES 64 0.0078
305 FOOT FRACTURE 148 0.0078
306 CARDIAC OPERATION 67 0.0078
307 MICTURITION URGENCY 89 0.0078
308 DIABETES MELLITUS 593 0.0078
309 PALPITATIONS 911 0.0078
310 WEIGHT FLUCTUATION 81 0.0077
311 COUGH 2170 0.0077
312 SINUSITIS 793 0.0077
313 CARDIAC PACEMAKER INSERTION 46 0.0077
314 SCIATICA 123 0.0077
315 BLOOD CREATININE INCREASED 502 0.0077
316 JOINT EFFUSION 53 0.0077
317 DYSURIA 282 0.0077
318 BLOOD CALCIUM INCREASED 67 0.0076
319 ARTHRALGIA 3164 0.0076
320 NECK PAIN 425 0.0076
321 PHOTOPSIA 48 0.0076
322 INFUSION SITE ERYTHEMA 64 0.0076
323 FALL 2509 0.0075
324 GAMMA-GLUTAMYLTRANSFERASE INCREASED 167 0.0075
325 SPINAL PAIN 88 0.0075
326 PAIN IN JAW 212 0.0075
327 POLYURIA 61 0.0074
328 ARTHROPATHY 414 0.0074
329 NASAL DISCOMFORT 59 0.0074
330 WALKING AID USER 49 0.0074
331 CARPAL TUNNEL SYNDROME 104 0.0074
332 BURSITIS 90 0.0074
333 COLITIS ISCHAEMIC 50 0.0074
334 DIZZINESS 3694 0.0074
335 MULTIPLE ALLERGIES 58 0.0074
336 CONTUSION 710 0.0074
337 POLLAKIURIA 307 0.0074
338 HYPOTHYROIDISM 235 0.0074
339 BRADYCARDIA 390 0.0073
340 LIMB DISCOMFORT 227 0.0073
341 MUSCULOSKELETAL PAIN 384 0.0073
342 BODY TEMPERATURE DECREASED 72 0.0073
343 RECTAL HAEMORRHAGE 314 0.0073
344 IMPAIRED QUALITY OF LIFE 105 0.0073
345 LOW BIRTH WEIGHT BABY 58 0.0073
346 MIDDLE INSOMNIA 136 0.0073
347 ORAL HERPES 142 0.0073
348 ABDOMINAL PAIN UPPER 1490 0.0072
349 GASTROINTESTINAL DISORDER 647 0.0072
350 SKIN LESION 198 0.0072
351 HEPATIC FUNCTION ABNORMAL 269 0.0072
352 SWOLLEN TONGUE 225 0.0072
353 ARRHYTHMIA 341 0.0072
354 ANKLE FRACTURE 111 0.0072
355 RENAL PAIN 76 0.0072
356 MUSCLE TIGHTNESS 116 0.0072
357 ECCHYMOSIS 49 0.0071
358 CHOLELITHIASIS 234 0.0071
359 BLOOD GLUCOSE FLUCTUATION 78 0.0071
360 ABDOMINAL DISCOMFORT 1193 0.0071
361 HYPOTENSION 1426 0.0071
362 LIMB INJURY 193 0.0071
363 FULL BLOOD COUNT ABNORMAL 75 0.0071
364 INTERVERTEBRAL DISC PROTRUSION 155 0.0071
365 HEART RATE IRREGULAR 160 0.0071
366 CHILLS 828 0.0071
367 CHOLECYSTITIS 84 0.0070
368 DRY MOUTH 572 0.0070
369 ABDOMINAL PAIN 1640 0.0070
370 HEPATITIS 179 0.0070
371 DYSSTASIA 204 0.0070
372 ATRIOVENTRICULAR BLOCK 54 0.0070
373 GASTROINTESTINAL HAEMORRHAGE 582 0.0070
374 INCREASED TENDENCY TO BRUISE 64 0.0069
375 FACIAL PAIN 62 0.0069
376 WRIST FRACTURE 83 0.0069
377 INFLUENZA LIKE ILLNESS 568 0.0069
378 EXOSTOSIS 63 0.0069
379 BLOOD POTASSIUM INCREASED 112 0.0069
380 SKIN DISORDER 230 0.0069
381 DRY THROAT 70 0.0069
382 THERAPY CESSATION 352 0.0069
383 CONSTIPATION 1495 0.0068
384 CONCUSSION 53 0.0068
385 BLOOD POTASSIUM DECREASED 205 0.0068
386 INJECTION SITE EXTRAVASATION 84 0.0068
387 VISION BLURRED 934 0.0068
388 GASTRIC ULCER 129 0.0068
389 METABOLIC ACIDOSIS 217 0.0068
390 DYSPHAGIA 643 0.0068
391 PERIPHERAL COLDNESS 93 0.0068
392 HAEMATOCRIT DECREASED 134 0.0068
393 COMA 321 0.0067
394 WEIGHT DECREASED 1881 0.0067
395 OSTEOPOROSIS 277 0.0067
396 DEFAECATION URGENCY 47 0.0067
397 SUPRAVENTRICULAR TACHYCARDIA 64 0.0067
398 HYPERTENSION 1412 0.0067
399 NEURALGIA 162 0.0067
400 ORAL PAIN 149 0.0066
401 ABDOMINAL DISTENSION 694 0.0066
402 ANHEDONIA 174 0.0066
403 FATIGUE 5145 0.0066
404 BLOOD MAGNESIUM DECREASED 57 0.0066
405 PRODUCT ODOUR ABNORMAL 69 0.0066
406 CARDIOMEGALY 81 0.0066
407 DYSPHONIA 385 0.0066
408 BLOOD TESTOSTERONE DECREASED 45 0.0066
409 RHINITIS 53 0.0066
410 BLOOD ALKALINE PHOSPHATASE INCREASED 163 0.0066
411 HAEMATOCHEZIA 362 0.0066
412 LIP SWELLING 218 0.0065
413 GAIT DISTURBANCE 1249 0.0065
414 RED BLOOD CELL SEDIMENTATION RATE INCREASED 72 0.0065
415 SLEEP DISORDER 458 0.0065
416 LIVER FUNCTION TEST INCREASED 139 0.0065
417 PRURITUS GENERALISED 140 0.0065
418 DECREASED APPETITE 1503 0.0065
419 EPISTAXIS 484 0.0065
420 TACHYCARDIA 573 0.0064
421 ANAL INCONTINENCE 58 0.0064
422 APHTHOUS ULCER 50 0.0064
423 IRRITABLE BOWEL SYNDROME 138 0.0064
424 BLOOD ALBUMIN DECREASED 51 0.0064
425 THYROID DISORDER 99 0.0064
426 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 334 0.0064
427 HYPOCALCAEMIA 121 0.0064
428 PARAESTHESIA ORAL 92 0.0064
429 DIARRHOEA 4115 0.0064
430 EJECTION FRACTION DECREASED 99 0.0064
431 SUBDURAL HAEMATOMA 91 0.0064
432 PARAESTHESIA 999 0.0063
433 INITIAL INSOMNIA 65 0.0063
434 CELLULITIS 319 0.0063
435 EAR PAIN 123 0.0063
436 PETECHIAE 66 0.0063
437 OEDEMA 343 0.0063
438 FOOT DEFORMITY 70 0.0063
439 DYSPNOEA 3566 0.0063
440 URINE OUTPUT DECREASED 55 0.0063
441 CEREBROVASCULAR ACCIDENT 1064 0.0063
442 BLOOD PRESSURE DECREASED 417 0.0063
443 LIVER INJURY 154 0.0063
444 ABSCESS 100 0.0063
445 BLOOD GLUCOSE INCREASED 1176 0.0062
446 CARDIAC FAILURE 500 0.0062
447 CONFUSIONAL STATE 1006 0.0062
448 CEREBRAL INFARCTION 152 0.0062
449 AGEUSIA 155 0.0062
450 MACULAR DEGENERATION 74 0.0062
451 BLOOD GLUCOSE ABNORMAL 114 0.0062
452 SPINAL COMPRESSION FRACTURE 51 0.0062
453 TOOTH FRACTURE 68 0.0062
454 OROPHARYNGEAL PAIN 571 0.0062
455 FEELING HOT 378 0.0062
456 MUSCULOSKELETAL STIFFNESS 540 0.0062
457 GINGIVAL PAIN 49 0.0062
458 DEHYDRATION 821 0.0061
459 HAEMORRHOIDS 120 0.0061
460 ACIDOSIS 47 0.0061
461 URINARY TRACT INFECTION 1049 0.0061
462 HYPERGLYCAEMIA 224 0.0061
463 PRURITUS 2362 0.0061
464 LOWER RESPIRATORY TRACT INFECTION 279 0.0061
465 HYPOXIA 216 0.0061
466 LOCALISED INFECTION 148 0.0061
467 ELECTROLYTE IMBALANCE 71 0.0061
468 NIGHTMARE 211 0.0061
469 DISORIENTATION 241 0.0061
470 BLOOD GLUCOSE DECREASED 292 0.0061
471 RIB FRACTURE 125 0.0061
472 GAIT INABILITY 203 0.0061
473 TENDONITIS 94 0.0061
474 BRONCHITIS 449 0.0061
475 BALANCE DISORDER 524 0.0061
476 ABORTION INDUCED 57 0.0060
477 RETCHING 129 0.0060
478 PHARYNGITIS 75 0.0060
479 UPPER RESPIRATORY TRACT INFECTION 279 0.0060
480 BACK DISORDER 98 0.0060
481 TRANSAMINASES INCREASED 134 0.0060
482 COLD SWEAT 106 0.0060
483 HEPATOMEGALY 59 0.0060
484 VITREOUS FLOATERS 59 0.0060
485 HYPOKINESIA 87 0.0060
486 HAEMATOMA 155 0.0060
487 INSOMNIA 1591 0.0060
488 OXYGEN SATURATION DECREASED 335 0.0060
489 BASAL CELL CARCINOMA 93 0.0060
490 HYPONATRAEMIA 335 0.0059
491 WOUND INFECTION 65 0.0059
492 BONE DISORDER 108 0.0059
493 HAEMOLYTIC ANAEMIA 53 0.0059
494 VERTIGO 360 0.0059
495 BURNING SENSATION 414 0.0059
496 RASH MACULO-PAPULAR 131 0.0059
497 RENAL DISORDER 274 0.0059
498 CARDIAC DISORDER 547 0.0058
499 FIBROMYALGIA 142 0.0058
500 HYPERHIDROSIS 752 0.0058
501 TRANSFUSION 61 0.0058
502 EOSINOPHILIA 102 0.0058
503 CARDIOMYOPATHY 86 0.0058
504 INFLUENZA 648 0.0058
505 EYE IRRITATION 334 0.0058
506 ANAEMIA 1106 0.0058
507 RASH PRURITIC 314 0.0058
508 GINGIVAL BLEEDING 79 0.0058
509 NAUSEA 4572 0.0058
510 LUNG INFILTRATION 51 0.0058
511 COAGULOPATHY 96 0.0058
512 POST PROCEDURAL HAEMORRHAGE 67 0.0057
513 BLOOD DISORDER 46 0.0057
514 ABDOMINAL PAIN LOWER 145 0.0057
515 THROAT IRRITATION 257 0.0057
516 INTERSTITIAL LUNG DISEASE 277 0.0057
517 PRODUCT PHYSICAL ISSUE 115 0.0057
518 PRODUCTIVE COUGH 272 0.0057
519 TOOTH ABSCESS 58 0.0057
520 SINUS BRADYCARDIA 55 0.0057
521 BLOOD URINE PRESENT 108 0.0057
522 INTERNAL HAEMORRHAGE 65 0.0057
523 SCRATCH 60 0.0057
524 GASTROENTERITIS 83 0.0057
525 HYPERSOMNIA 163 0.0057
526 WEIGHT INCREASED 1272 0.0057
527 DECREASED ACTIVITY 61 0.0056
528 EMPHYSEMA 57 0.0056
529 SEPSIS 629 0.0056
530 NERVE COMPRESSION 52 0.0056
531 IMPAIRED WORK ABILITY 120 0.0056
532 INCREASED APPETITE 107 0.0056
533 POLYNEUROPATHY 67 0.0056
534 HEADACHE 3507 0.0056
535 CARDIOGENIC SHOCK 80 0.0056
536 HYPOKALAEMIA 257 0.0056
537 HIP FRACTURE 179 0.0056
538 WHEEZING 330 0.0056
539 NASAL CONGESTION 327 0.0056
540 LETHARGY 320 0.0056
541 PNEUMONIA BACTERIAL 51 0.0056
542 ABASIA 137 0.0055
543 MOVEMENT DISORDER 178 0.0055
544 RED BLOOD CELL COUNT DECREASED 158 0.0055
545 PULMONARY HYPERTENSION 115 0.0055
546 NEUROPATHY PERIPHERAL 525 0.0055
547 BONE PAIN 323 0.0055
548 PULMONARY MASS 82 0.0055
549 JOINT SWELLING 662 0.0055
550 ILEUS 68 0.0055
551 CLOSTRIDIUM DIFFICILE COLITIS 58 0.0055
552 DRY EYE 273 0.0055
553 ORAL CANDIDIASIS 72 0.0055
554 NIGHT SWEATS 176 0.0055
555 PERIPHERAL SWELLING 840 0.0054
556 PALLOR 148 0.0054
557 SENSORY DISTURBANCE 87 0.0054
558 RASH MACULAR 189 0.0054
559 MEDICATION ERROR 300 0.0054
560 SLUGGISHNESS 55 0.0054
561 EYE DISCHARGE 56 0.0054
562 MALAISE 2363 0.0054
563 SKIN EXFOLIATION 454 0.0054
564 ASTHMA 608 0.0054
565 URINARY INCONTINENCE 159 0.0054
566 NEPHROLITHIASIS 246 0.0054
567 DRUG ERUPTION 95 0.0054
568 AMNESIA 348 0.0053
569 HYPERCALCAEMIA 66 0.0053
570 SKIN ULCER 138 0.0053
571 JOINT STIFFNESS 140 0.0053
572 HERPES ZOSTER 306 0.0053
573 TASTE DISORDER 108 0.0053
574 LIVER DISORDER 236 0.0053
575 PULMONARY FIBROSIS 102 0.0053
576 ACUTE RESPIRATORY FAILURE 102 0.0053
577 PRODUCT PRESCRIBING ERROR 126 0.0053
578 FLUID RETENTION 269 0.0053
579 PRODUCT DISTRIBUTION ISSUE 49 0.0053
580 SPINAL DISORDER 50 0.0053
581 LIGAMENT SPRAIN 52 0.0053
582 NEPHROPATHY TOXIC 59 0.0053
583 VOMITING 2470 0.0052
584 HAEMOGLOBIN DECREASED 539 0.0052
585 TOOTHACHE 95 0.0052
586 DERMATITIS ALLERGIC 66 0.0052
587 EYE HAEMORRHAGE 70 0.0052
588 GLAUCOMA 101 0.0052
589 JOINT INJURY 112 0.0052
590 BACK INJURY 57 0.0052
591 BLADDER DISORDER 52 0.0052
592 INFLAMMATION 270 0.0052
593 CHOKING 102 0.0052
594 PNEUMONIA 1690 0.0052
595 ABNORMAL DREAMS 144 0.0052
596 FEELING COLD 145 0.0052
597 GENERAL PHYSICAL HEALTH DETERIORATION 602 0.0052
598 INFUSION SITE PAIN 67 0.0052
599 HYPOAESTHESIA 778 0.0052
600 DYSGEUSIA 386 0.0052
601 LEUKOCYTOSIS 94 0.0052
602 SCAB 59 0.0052
603 MYOCARDITIS 59 0.0051
604 BLOOD SODIUM DECREASED 97 0.0051
605 TOOTH EXTRACTION 64 0.0051
606 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 247 0.0051
607 DRUG EFFECT LESS THAN EXPECTED 76 0.0051
608 ANOREXIA 66 0.0051
609 HEAD INJURY 162 0.0051
610 LACERATION 48 0.0051
611 ISCHAEMIC STROKE 91 0.0051
612 OROPHARYNGEAL DISCOMFORT 46 0.0051
613 JOINT RANGE OF MOTION DECREASED 68 0.0051
614 PULMONARY OEDEMA 227 0.0051
615 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 52 0.0051
616 DENTAL CARIES 56 0.0051
617 DISABILITY 100 0.0051
618 BLOOD IRON DECREASED 60 0.0051
619 DEPRESSION 1148 0.0050
620 VENTRICULAR FIBRILLATION 56 0.0050
621 GASTROENTERITIS VIRAL 91 0.0050
622 HYPERTENSIVE CRISIS 56 0.0050
623 C-REACTIVE PROTEIN INCREASED 183 0.0050
624 POOR VENOUS ACCESS 52 0.0050
625 HERNIA 97 0.0050
626 INCONTINENCE 53 0.0050
627 FUNGAL INFECTION 167 0.0050
628 CARDIOVASCULAR DISORDER 127 0.0050
629 PLEURAL EFFUSION 304 0.0050
630 NERVOUSNESS 261 0.0050
631 NASOPHARYNGITIS 920 0.0050
632 CIRCULATORY COLLAPSE 85 0.0050
633 EAR DISCOMFORT 51 0.0050
634 CEREBRAL HAEMORRHAGE 177 0.0049
635 HYPOPHAGIA 126 0.0049
636 HYPERBILIRUBINAEMIA 51 0.0049
637 DIABETIC KETOACIDOSIS 118 0.0049
638 DERMATITIS CONTACT 56 0.0049
639 HYPOAESTHESIA ORAL 74 0.0049
640 PHOTOSENSITIVITY REACTION 81 0.0049
641 ACUTE HEPATIC FAILURE 67 0.0049
642 HIP ARTHROPLASTY 75 0.0049
643 PARALYSIS 70 0.0049
644 PERICARDIAL EFFUSION 113 0.0049
645 SQUAMOUS CELL CARCINOMA 46 0.0049
646 PNEUMONITIS 133 0.0049
647 BLOOD COUNT ABNORMAL 74 0.0049
648 PNEUMOCYSTIS JIROVECII PNEUMONIA 49 0.0049
649 VIRAL INFECTION 162 0.0049
650 GASTRIC DISORDER 167 0.0049
651 PAIN 2984 0.0049
652 SOMNOLENCE 977 0.0048
653 HEART RATE INCREASED 480 0.0048
654 HAIR COLOUR CHANGES 60 0.0048
655 TREMOR 800 0.0048
656 THIRST 86 0.0048
657 COLITIS 182 0.0048
658 MASS 67 0.0048
659 SMALL INTESTINAL OBSTRUCTION 59 0.0048
660 FEEDING DISORDER 97 0.0048
661 PULMONARY THROMBOSIS 52 0.0048
662 THROAT TIGHTNESS 129 0.0048
663 DEMENTIA 133 0.0048
664 LOSS OF CONSCIOUSNESS 609 0.0047
665 OSTEOMYELITIS 86 0.0047
666 ANXIETY 1348 0.0047
667 INTENTIONAL DOSE OMISSION 135 0.0047
668 GLOSSODYNIA 106 0.0047
669 CHOLECYSTECTOMY 54 0.0047
670 FULL BLOOD COUNT DECREASED 95 0.0047
671 MYOCLONUS 56 0.0047
672 HALLUCINATION, VISUAL 99 0.0047
673 LABORATORY TEST ABNORMAL 138 0.0047
674 CYST 58 0.0047
675 BLISTER 262 0.0047
676 HAEMOPTYSIS 130 0.0047
677 DISTURBANCE IN ATTENTION 251 0.0046
678 GALLBLADDER DISORDER 83 0.0046
679 JAUNDICE 125 0.0046
680 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 330 0.0046
681 ATAXIA 55 0.0046
682 LOWER LIMB FRACTURE 89 0.0046
683 RHEUMATOID ARTHRITIS 525 0.0046
684 SWELLING FACE 301 0.0046
685 PHARYNGEAL OEDEMA 71 0.0046
686 RESPIRATORY TRACT INFECTION 120 0.0046
687 BREAST PAIN 49 0.0046
688 HEPATOTOXICITY 102 0.0046
689 IMPAIRED DRIVING ABILITY 52 0.0046
690 COVID-19 PNEUMONIA 54 0.0046
691 FACE OEDEMA 77 0.0046
692 RASH ERYTHEMATOUS 218 0.0046
693 PYREXIA 1576 0.0045
694 PULMONARY CONGESTION 60 0.0045
695 EYE SWELLING 169 0.0045
696 RASH 1980 0.0045
697 ORAL DISCOMFORT 63 0.0045
698 OCULAR HYPERAEMIA 215 0.0045
699 PRODUCT ADMINISTRATION ERROR 91 0.0045
700 SWELLING 421 0.0045
701 TOOTH DISORDER 100 0.0045
702 HALLUCINATION 338 0.0045
703 KIDNEY INFECTION 88 0.0045
704 ANGIOEDEMA 198 0.0045
705 FEELING ABNORMAL 1072 0.0045
706 URINARY RETENTION 149 0.0045
707 FREQUENT BOWEL MOVEMENTS 120 0.0044
708 WOUND 124 0.0044
709 MEMORY IMPAIRMENT 609 0.0044
710 MOBILITY DECREASED 317 0.0044
711 TOOTH INFECTION 58 0.0044
712 SHOCK 101 0.0044
713 LACRIMATION INCREASED 132 0.0044
714 COVID-19 765 0.0044
715 DISCOMFORT 266 0.0044
716 LOCAL SWELLING 76 0.0044
717 BLOOD LACTATE DEHYDROGENASE INCREASED 69 0.0044
718 FEAR 117 0.0043
719 ANAPHYLACTIC REACTION 240 0.0043
720 QUALITY OF LIFE DECREASED 58 0.0043
721 POST PROCEDURAL COMPLICATION 83 0.0043
722 DEAFNESS 113 0.0043
723 INJECTION SITE BRUISING 344 0.0043
724 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 73 0.0043
725 MUSCLE TWITCHING 99 0.0043
726 INTENTIONAL PRODUCT MISUSE 376 0.0043
727 DEPRESSED MOOD 227 0.0043
728 RESTLESSNESS 156 0.0043
729 CARDIAC ARREST 351 0.0042
730 PSORIASIS 555 0.0042
731 RASH PAPULAR 95 0.0042
732 SECRETION DISCHARGE 53 0.0042
733 UPPER LIMB FRACTURE 84 0.0042
734 ULCER 67 0.0042
735 UNEVALUABLE EVENT 318 0.0042
736 FEELING JITTERY 80 0.0042
737 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 108 0.0042
738 SPINAL FRACTURE 84 0.0042
739 THERAPEUTIC RESPONSE UNEXPECTED 188 0.0042
740 ACCIDENT 50 0.0042
741 UNRESPONSIVE TO STIMULI 108 0.0042
742 BLINDNESS UNILATERAL 59 0.0042
743 NEOPLASM 48 0.0042
744 STOMATITIS 253 0.0042
745 ECZEMA 218 0.0042
746 SPEECH DISORDER 218 0.0042
747 METASTASES TO LIVER 73 0.0041
748 ACTIVITIES OF DAILY LIVING IMPAIRED 82 0.0041
749 BIPOLAR DISORDER 45 0.0041
750 NODULE 54 0.0041
751 PNEUMONIA ASPIRATION 103 0.0041
752 ILLNESS 423 0.0041
753 SKIN CANCER 88 0.0041
754 APHONIA 57 0.0041
755 BLOOD BILIRUBIN INCREASED 110 0.0041
756 INTRAOCULAR PRESSURE INCREASED 52 0.0041
757 PRODUCT TASTE ABNORMAL 55 0.0041
758 PHARMACEUTICAL PRODUCT COMPLAINT 105 0.0040
759 VISUAL ACUITY REDUCED 134 0.0040
760 MULTIPLE ORGAN DYSFUNCTION SYNDROME 114 0.0040
761 INTESTINAL OBSTRUCTION 151 0.0040
762 RESPIRATORY FAILURE 292 0.0040
763 CONDITION AGGRAVATED 1217 0.0040
764 URTICARIA 670 0.0040
765 ADVERSE REACTION 53 0.0040
766 SCAR 68 0.0040
767 HAIR TEXTURE ABNORMAL 53 0.0040
768 MENTAL STATUS CHANGES 110 0.0040
769 HEPATOCELLULAR INJURY 56 0.0039
770 WRONG TECHNIQUE IN DRUG USAGE PROCESS 143 0.0039
771 INSURANCE ISSUE 60 0.0039
772 BODY TEMPERATURE INCREASED 80 0.0039
773 ALOPECIA 770 0.0039
774 EYE DISORDER 128 0.0039
775 DISEASE RECURRENCE 185 0.0039
776 SKIN FISSURES 76 0.0039
777 HEPATIC CIRRHOSIS 73 0.0039
778 DIALYSIS 55 0.0039
779 CANDIDA INFECTION 65 0.0038
780 MOUTH ULCERATION 81 0.0038
781 HALLUCINATION, AUDITORY 61 0.0038
782 LUNG DISORDER 187 0.0038
783 SPINAL OPERATION 47 0.0038
784 EYE PRURITUS 128 0.0038
785 THERAPY NON-RESPONDER 171 0.0038
786 BONE DENSITY DECREASED 119 0.0038
787 DRUG DISPENSING ERROR 58 0.0038
788 PSORIATIC ARTHROPATHY 154 0.0038
789 PRODUCT SUBSTITUTION ISSUE 217 0.0038
790 PLATELET COUNT INCREASED 49 0.0038
791 WHITE BLOOD CELL COUNT INCREASED 144 0.0037
792 ANOSMIA 54 0.0037
793 LYMPHADENOPATHY 132 0.0037
794 INJURY 262 0.0037
795 HYPERSENSITIVITY 690 0.0037
796 DYSKINESIA 151 0.0037
797 THERAPY INTERRUPTED 265 0.0037
798 MULTI-ORGAN FAILURE 64 0.0037
799 TREATMENT NONCOMPLIANCE 202 0.0037
800 DRUG LEVEL INCREASED 61 0.0037
801 LUNG NEOPLASM MALIGNANT 151 0.0037
802 HUNGER 51 0.0037
803 VISUAL IMPAIRMENT 453 0.0037
804 BACTERIAL INFECTION 68 0.0036
805 BRONCHOSPASM 52 0.0036
806 RESPIRATORY DISTRESS 100 0.0036
807 THROMBOCYTOPENIA 405 0.0036
808 SKIN DISCOLOURATION 166 0.0036
809 PRODUCT DOSE OMISSION ISSUE 1059 0.0036
810 MIGRAINE 342 0.0036
811 SURGERY 209 0.0036
812 ERYTHEMA 732 0.0036
813 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 253 0.0036
814 RASH GENERALISED 92 0.0035
815 SYNOVITIS 64 0.0035
816 SOPOR 47 0.0035
817 THINKING ABNORMAL 66 0.0035
818 DEEP VEIN THROMBOSIS 229 0.0035
819 HEPATIC FAILURE 106 0.0035
820 ADVERSE EVENT 324 0.0035
821 WHITE BLOOD CELL COUNT DECREASED 381 0.0035
822 MUCOSAL INFLAMMATION 92 0.0035
823 PRODUCT USE COMPLAINT 55 0.0035
824 ROAD TRAFFIC ACCIDENT 146 0.0035
825 COLON CANCER 52 0.0035
826 IMPAIRED HEALING 114 0.0035
827 PNEUMOTHORAX 55 0.0035
828 MENTAL IMPAIRMENT 84 0.0035
829 THROMBOSIS 278 0.0035
830 PANCYTOPENIA 193 0.0034
831 ANAPHYLACTIC SHOCK 89 0.0034
832 MALIGNANT MELANOMA 46 0.0034
833 BEDRIDDEN 45 0.0034
834 PRODUCT DOSE OMISSION IN ERROR 96 0.0034
835 EAR INFECTION 90 0.0034
836 FEBRILE NEUTROPENIA 224 0.0034
837 RESPIRATORY DISORDER 101 0.0034
838 LYMPHOMA 52 0.0034
839 PANCREATIC CARCINOMA 97 0.0034
840 IMMUNODEFICIENCY 50 0.0034
841 PLATELET COUNT DECREASED 357 0.0033
842 DELIRIUM 115 0.0033
843 PRESCRIBED OVERDOSE 64 0.0033
844 CRYING 120 0.0033
845 MOOD ALTERED 90 0.0033
846 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 56 0.0033
847 MUSCULOSKELETAL DISORDER 62 0.0033
848 INTENTIONAL PRODUCT USE ISSUE 285 0.0033
849 DEVICE RELATED INFECTION 50 0.0032
850 COGNITIVE DISORDER 151 0.0032
851 MULTIPLE FRACTURES 53 0.0032
852 INJECTION SITE HAEMORRHAGE 257 0.0032
853 HAEMORRHAGE 336 0.0032
854 PRESCRIBED UNDERDOSE 64 0.0032
855 PRODUCT DOSE OMISSION 209 0.0032
856 INFUSION RELATED REACTION 211 0.0032
857 STAPHYLOCOCCAL INFECTION 105 0.0032
858 PANIC ATTACK 116 0.0032
859 EMOTIONAL DISORDER 98 0.0032
860 METASTASES TO BONE 52 0.0032
861 LYMPHOCYTE COUNT DECREASED 56 0.0032
862 ILL-DEFINED DISORDER 192 0.0032
863 APATHY 46 0.0032
864 PELVIC PAIN 57 0.0031
865 STEVENS-JOHNSON SYNDROME 69 0.0031
866 FEMUR FRACTURE 96 0.0031
867 INJECTION SITE MASS 114 0.0031
868 CONJUNCTIVITIS 57 0.0031
869 PULMONARY EMBOLISM 290 0.0030
870 ADVERSE DRUG REACTION 273 0.0030
871 CONTRAINDICATED PRODUCT ADMINISTERED 92 0.0030
872 DEPRESSED LEVEL OF CONSCIOUSNESS 120 0.0030
873 OSTEONECROSIS OF JAW 75 0.0030
874 CLOSTRIDIUM DIFFICILE INFECTION 66 0.0030
875 ELECTROCARDIOGRAM QT PROLONGED 108 0.0030
876 ANGER 101 0.0030
877 INJECTION SITE PRURITUS 200 0.0030
878 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 537 0.0030
879 LEUKOPENIA 146 0.0029
880 SEPTIC SHOCK 127 0.0029
881 DRUG EFFECT INCOMPLETE 106 0.0029
882 DRUG INEFFECTIVE 3829 0.0029
883 SYSTEMIC LUPUS ERYTHEMATOSUS 103 0.0029
884 DRY SKIN 386 0.0029
885 AGRANULOCYTOSIS 53 0.0028
886 OFF LABEL USE 2492 0.0028
887 PARANOIA 49 0.0028
888 HYPOACUSIS 122 0.0028
889 ACUTE RESPIRATORY DISTRESS SYNDROME 50 0.0028
890 PRODUCT AVAILABILITY ISSUE 64 0.0028
891 PERICARDITIS 47 0.0028
892 DRUG DOSE OMISSION 461 0.0028
893 THERAPEUTIC RESPONSE DECREASED 169 0.0028
894 INJECTION SITE PAIN 852 0.0028
895 PRODUCT USE IN UNAPPROVED INDICATION 688 0.0028
896 PROCEDURAL PAIN 77 0.0028
897 INJECTION SITE RASH 85 0.0028
898 DERMATITIS 58 0.0028
899 OSTEONECROSIS 90 0.0027
900 EMOTIONAL DISTRESS 325 0.0027
901 THERAPEUTIC RESPONSE SHORTENED 89 0.0027
902 DRUG EFFECT DECREASED 144 0.0027
903 NEOPLASM MALIGNANT 177 0.0026
904 COLITIS ULCERATIVE 118 0.0026
905 PAIN OF SKIN 71 0.0026
906 EXPOSURE VIA SKIN CONTACT 68 0.0026
907 MENTAL DISORDER 114 0.0026
908 MOOD SWINGS 83 0.0026
909 DRUG PRESCRIBING ERROR 50 0.0026
910 DERMATITIS ATOPIC 137 0.0026
911 INFECTION 376 0.0026
912 SKIN BURNING SENSATION 186 0.0026
913 INTENTIONAL DRUG MISUSE 54 0.0026
914 IRRITABILITY 155 0.0026
915 DRUG ADMINISTRATION ERROR 79 0.0026
916 INJECTION SITE ERYTHEMA 318 0.0026
917 AGGRESSION 128 0.0026
918 SUICIDAL IDEATION 234 0.0026
919 INJECTION SITE SWELLING 193 0.0025
920 PRODUCT USE ISSUE 470 0.0025
921 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 58 0.0025
922 PRODUCT PREPARATION ERROR 51 0.0025
923 AGITATION 182 0.0025
924 DEVICE DIFFICULT TO USE 164 0.0025
925 PERITONITIS 51 0.0025
926 ACCIDENTAL OVERDOSE 90 0.0025
927 TARDIVE DYSKINESIA 69 0.0024
928 FRACTURE 46 0.0024
929 SEIZURE 280 0.0024
930 THERAPEUTIC PRODUCT EFFECT DECREASED 108 0.0024
931 NEUTROPHIL COUNT DECREASED 98 0.0024
932 CONVULSION 137 0.0024
933 UNDERDOSE 171 0.0023
934 PSYCHOTIC DISORDER 69 0.0023
935 DISEASE PROGRESSION 272 0.0023
936 PRODUCT QUALITY ISSUE 310 0.0023
937 ENCEPHALOPATHY 56 0.0023
938 NERVOUS SYSTEM DISORDER 70 0.0022
939 INJECTION SITE URTICARIA 55 0.0022
940 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 453 0.0022
941 GYNAECOMASTIA 68 0.0022
942 INJECTION SITE REACTION 150 0.0022
943 INCORRECT DOSE ADMINISTERED 494 0.0022
944 INCORRECT DOSE ADMINISTERED BY DEVICE 56 0.0021
945 INCORRECT PRODUCT ADMINISTRATION DURATION 46 0.0021
946 EXTRAPYRAMIDAL DISORDER 51 0.0021
947 DRUG ABUSE 169 0.0020
948 TREATMENT FAILURE 168 0.0020
949 PREMATURE BABY 61 0.0020
950 ACCIDENTAL EXPOSURE TO PRODUCT 208 0.0020
951 DEVICE MALFUNCTION 140 0.0020
952 APPLICATION SITE PRURITUS 45 0.0020
953 HOSPITALISATION 304 0.0020
954 NEEDLE ISSUE 57 0.0020
955 PLASMA CELL MYELOMA 73 0.0019
956 RESPIRATORY ARREST 51 0.0018
957 NEOPLASM PROGRESSION 63 0.0018
958 OVERDOSE 385 0.0018
959 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 59 0.0017
960 INCORRECT DRUG ADMINISTRATION DURATION 49 0.0017
961 APPLICATION SITE ERYTHEMA 45 0.0017
962 EXPIRED PRODUCT ADMINISTERED 57 0.0017
963 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 94 0.0017
964 TOXICITY TO VARIOUS AGENTS 285 0.0017
965 SKIN IRRITATION 77 0.0017
966 MALIGNANT NEOPLASM PROGRESSION 170 0.0017
967 EXTRA DOSE ADMINISTERED 67 0.0017
968 NEUTROPENIA 220 0.0016
969 EPILEPSY 49 0.0016
970 ABNORMAL BEHAVIOUR 63 0.0016
971 DEVICE ISSUE 139 0.0015
972 DEATH 1327 0.0015
973 PROSTATE CANCER 121 0.0015
974 BREAST CANCER 138 0.0015
975 NO ADVERSE EVENT 268 0.0015
976 WITHDRAWAL SYNDROME 61 0.0015
977 BLADDER CANCER 85 0.0014
978 COMPLETED SUICIDE 117 0.0014
979 DRUG DOSE OMISSION BY DEVICE 108 0.0014
980 PRODUCT ADHESION ISSUE 49 0.0014
981 INTENTIONAL OVERDOSE 84 0.0013
982 PRODUCT STORAGE ERROR 113 0.0013
983 MULTIPLE SCLEROSIS RELAPSE 88 0.0013
984 DEVICE DISLOCATION 55 0.0013
985 FOETAL EXPOSURE DURING PREGNANCY 102 0.0013
986 MULTIPLE SCLEROSIS 58 0.0012
987 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 55 0.0012
988 ACNE 88 0.0012
989 VAGINAL HAEMORRHAGE 46 0.0011
990 SUICIDE ATTEMPT 58 0.0010
991 EXPOSURE DURING PREGNANCY 54 0.0009
992 DRUG WITHDRAWAL SYNDROME 76 0.0009
993 MATERNAL EXPOSURE DURING PREGNANCY 59 0.0007
994 DRUG DEPENDENCE 84 0.0005